(NASDAQ: SION) Sionna Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.
Sionna Therapeutics's earnings in 2025 is -$61,688,000.On average, 2 Wall Street analysts forecast SION's earnings for 2025 to be -$97,073,667, with the lowest SION earnings forecast at -$98,838,643, and the highest SION earnings forecast at -$95,308,691.
In 2026, SION is forecast to generate -$103,251,082 in earnings, with the lowest earnings forecast at -$106,781,033 and the highest earnings forecast at -$99,721,130.